Published in Gene Therapy Weekly, August 9th, 1999
A. Horster and colleagues from the Deutsches Krebsforschungszentrum, Germany, suggested that vector-mediated delivery of potentially antivirally active genes is a key step in somatic gene therapy against AIDS ("Recombinant AAV-2 Harboring gfp-Antisense/Ribozyme Fusion Sequences Monitor Transduction, Gene Expression, and Show Anti-HIV-1 Efficacy," Gene Therapy, July 1999;6(7):1231-38).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.